应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
GUTS Fractyl Health
休市中 05-10 16:00:00 EDT
6.19
-0.03
-0.48%
盘后
6.19
+0.00
0.00%
19:57 EDT
最高
6.41
最低
6.12
成交量
14.92万
今开
6.30
昨收
6.22
日振幅
4.60%
总市值
2.96亿
流通市值
1.18亿
总股本
4,788万
成交额
93.69万
换手率
0.78%
流通股本
1,905万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
BUZZ-Fractyl Health 第四季度亏损扩大,业绩下滑
Reuters · 04-01
BUZZ-Fractyl Health 第四季度亏损扩大,业绩下滑
BUZZ-Fractyl Health 在 FDA 允许对体重管理设备进行研究后获得收益
Reuters · 04-01
BUZZ-Fractyl Health 在 FDA 允许对体重管理设备进行研究后获得收益
BUZZ-Fractyl 在小鼠中进行的肥胖症和糖尿病治疗试验前景看好
Reuters · 03-12
BUZZ-Fractyl 在小鼠中进行的肥胖症和糖尿病治疗试验前景看好
加载更多
公司概况
公司名称:
Fractyl Health
所属市场:
NASDAQ
上市日期:
--
主营业务:
Fractyl Health, Inc.于2010年8月30日根据特拉华州法律注册成立。该公司是一家代谢治疗公司,专注于开拓治疗代谢性疾病的新方法,包括2型糖尿病和肥胖症。根据疾病控制中心和国际糖尿病联合会的数据,美国大约有1亿人患有前驱糖尿病和肥胖症,另有2500万人患有糖尿病,正在接受药物治疗。他们的目标是开发持久的疾病改善疗法,旨在通过针对T2D和肥胖的器官水平根源,提供代谢健康的长期维持,而不需要终身治疗。
发行价格:
--
{"stockData":{"symbol":"GUTS","market":"US","secType":"STK","nameCN":"Fractyl Health","latestPrice":6.19,"timestamp":1715371200000,"preClose":6.22,"halted":0,"volume":149240,"hourTrading":{"tag":"盘后","latestPrice":6.19,"preClose":6.19,"latestTime":"19:57 EDT","volume":537,"amount":3337.72,"timestamp":1715385447402},"delay":0,"floatShares":19047325,"shares":47878269,"eps":-45.29368,"marketStatus":"休市中","marketStatusCode":7,"change":-0.03,"latestTime":"05-10 16:00:00 EDT","open":6.3,"high":6.41,"low":6.1238,"amount":936869.99406,"amplitude":0.046013,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-45.29368,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1715587200000},"adr":0,"listingDate":1706850000000,"adjPreClose":6.22,"preHourTrading":{"tag":"盘前","latestPrice":6.35,"preClose":6.22,"latestTime":"09:25 EDT","volume":864,"amount":5411.1594239999995,"timestamp":1715347500168},"postHourTrading":{"tag":"盘后","latestPrice":6.19,"preClose":6.19,"latestTime":"19:57 EDT","volume":537,"amount":3337.72,"timestamp":1715385447402},"volumeRatio":1.0408849347664946},"requestUrl":"/m/hq/s/GUTS","defaultTab":"news","newsList":[{"id":"2424711134","title":"BUZZ-Fractyl Health 第四季度亏损扩大,业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2424711134","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2424711134?lang=zh_cn&edition=full","pubTime":"2024-04-01 21:02","pubTimestamp":1711976562,"startTime":"0","endTime":"0","summary":" (更新) 4月1日 - ** Fractyl Health 股价盘前下跌约22%至5.80 美元 ** 公司报告第四季度净亏损1920万美元,合每股亏损11.18美元,去年同期亏损1090万美元,合每股亏损7.39美元。** 减肥设备 Revita 的销售和租赁收入 \"微不足道\",2023 年收入为 10 万美元 - GUTS ** Revita 已在欧洲获得批准,GUTS 去年已在德国启动了该设备的有限商业试点。** 截至上次收盘,GUTS 自 2 月 2 日上市以来下跌了 46.2","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2424792257","title":"BUZZ-Fractyl Health 在 FDA 允许对体重管理设备进行研究后获得收益","url":"https://stock-news.laohu8.com/highlight/detail?id=2424792257","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2424792257?lang=zh_cn&edition=full","pubTime":"2024-04-01 19:12","pubTimestamp":1711969935,"startTime":"0","endTime":"0","summary":" 4月1日 - ** Fractyl Health 股价在盘前交易中上涨 5.3% 至 7.79 美元 ** 该公司称,美国卫生监管机构已经批准了对其研究性设备Revita的减肥效果进行研究的申请。** Revita旨在通过手术重塑小肠的十二指肠内壁,十二指肠内壁接收来自胃部的食物并开始吸收营养。** 联合研究公司称,Remain-1 研究将测试 Revita 与假治疗的对比,测试对象是使用替扎帕肽后体重至少减轻 15%的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2418323135","title":"BUZZ-Fractyl 在小鼠中进行的肥胖症和糖尿病治疗试验前景看好","url":"https://stock-news.laohu8.com/highlight/detail?id=2418323135","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2418323135?lang=zh_cn&edition=full","pubTime":"2024-03-12 21:26","pubTimestamp":1710249963,"startTime":"0","endTime":"0","summary":" 3月12日 - ** Fractyl Health 股价盘前上涨18.5%至9.40美元** 该公司称, ,其治疗糖尿病和肥胖症的实验性基因疗法RJVA-001在4周的小鼠实验中实现了高达50%的血糖降低率和11%的体重减轻率,而semaglutide则实现了32%的血糖降低率和2%的体重减轻率。** 公司预计该疗法将于 2024 年获得 FDA 批准进行临床试验,并于 2025 年启动人体临床研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.fractyl.com","stockEarnings":[{"period":"1week","weight":-0.0492},{"period":"1month","weight":-0.1157},{"period":"3month","weight":-0.3829},{"period":"6month","weight":-0.5873},{"period":"ytd","weight":-0.5873}],"compareEarnings":[{"period":"1week","weight":0.0187},{"period":"1month","weight":0.0131},{"period":"3month","weight":0.0392},{"period":"6month","weight":0.1821},{"period":"1year","weight":0.2638},{"period":"ytd","weight":0.0958}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Fractyl Health, Inc.于2010年8月30日根据特拉华州法律注册成立。该公司是一家代谢治疗公司,专注于开拓治疗代谢性疾病的新方法,包括2型糖尿病和肥胖症。根据疾病控制中心和国际糖尿病联合会的数据,美国大约有1亿人患有前驱糖尿病和肥胖症,另有2500万人患有糖尿病,正在接受药物治疗。他们的目标是开发持久的疾病改善疗法,旨在通过针对T2D和肥胖的器官水平根源,提供代谢健康的长期维持,而不需要终身治疗。","exchange":"NASDAQ","name":"Fractyl Health","nameEN":"Fractyl Health"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Fractyl Health(GUTS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Fractyl Health(GUTS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Fractyl Health,GUTS,Fractyl Health股票,Fractyl Health股票老虎,Fractyl Health股票老虎国际,Fractyl Health行情,Fractyl Health股票行情,Fractyl Health股价,Fractyl Health股市,Fractyl Health股票价格,Fractyl Health股票交易,Fractyl Health股票购买,Fractyl Health股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Fractyl Health(GUTS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Fractyl Health(GUTS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}